المؤلفون: Fehm T; Department of Gynecology and Obstetrics, University of Erlangen-Nuremburg, Germany., Maimonis P, Weitz S, Teramoto Y, Katalinic A, Jäger W

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 1997 Mar; Vol. 43 (1), pp. 87-95.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print Cited Medium: Print ISSN: 0167-6806 (Print) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Breast Neoplasms/*blood , Breast Neoplasms/*drug therapy , Mitoxantrone/*administration & dosage , Receptor, ErbB-2/*blood, Breast Neoplasms/pathology ; Case-Control Studies ; Chemotherapy, Adjuvant ; Cyclophosphamide/administration & dosage ; Disease-Free Survival ; Female ; Fluorouracil/administration & dosage ; Humans ; Lymphatic Metastasis ; Methotrexate/administration & dosage ; Middle Aged ; Prognosis ; Retrospective Studies ; Survival Analysis

SCR Protocol: CMF regimen